“…In resistant mice (e.g., CBA), IFN-␥ is the principal mediator of resistance to L. major due to its ability to activate macrophages (M) 4 to destroy the parasite (12)(13)(14)(15), and treating mice with a neutralizing anti-IFN-␥ Ab exacerbates the course of infection by promoting the outgrowth of Th2 cells (16,17). In susceptible mice (BALB/c), IL-4 can block the ability of IFN-␥ to activate M to destroy Leishmania (18,19), and treating mice with a neutralizing anti-IL-4 Ab allows the animals to cure their infection by promoting the outgrowth of Th1 cells (20,21). In addition, other cells of the immune system, such as M, can produce cytokines and factors (e.g., IL-10, IL-12, nitric oxide (NO), and TGF-) that can modulate an immune response and influence the outcome of infection with L. major in mice (7)(8)(9)(10)(11).…”